You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Switzerland

May 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Switzerland with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Switzerland, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Switzerland for free:

The Consumer Health in Switzerland market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Switzerland?
  • What are the major brands in Switzerland?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

OTC market continues to grow

The OTC healthcare market demonstrated healthy growth in 2010, despite a weak economy and increasing competition from other industries. All categories other than ear care experienced growth in 2010. The declining performance of ear care is due to an increasing level of resistance to self medicating for such ailments. The fastest growing category was emergency contraception. Sales of the “Pille danach” (morning after pill) have increased rapidly since it was first introduced to the OTC market in 2002. The largest category remained cough, cold and allergy remedies. One factor contributing to the success of this category is the increasing number of allergy sufferers in Switzerland, which is estimated to be one-quarter of the population.

Alli enters Swiss OTC market

The well-known obesity medicine Orlistat entered the Swiss OTC market in January 2010. Orlistat, sold under the brand name Alli and produced by GlaxoSmithKline, has been available without prescription in most other European countries since 2009. Despite a relatively aggressive marketing campaign, Alli has yet to achieve the results GlaxoSmithKline may have hoped for. One reason for the slow uptake may be Swiss consumers’ wariness of medicines, fearing there may be negative side effects. According to industry experts sales of Alli will benefit if pharmacists are educated regarding the product and truly understand when and how it should be used.

OTC market receives competition from various other industries

In recent years manufacturers of various products have begun to market their products in a “scientific” manner leading consumers to believe that the product may have medicinal qualities. This is especially true with regard to the cosmetics industry. An excellent example of such marketing is the new Lancôme product Gènifique. The advertisements use words and phrases such as “in-vitro test on genes” or “stimulate the production of youth proteins” making a very scientific impression and giving the consumer the feeling that they are purchasing an over-the-counter medicated skin care product. As these categories seem to blend together, OTC medicated skin care producers will need to be proactive in order to minimise loss of sales to the cosmetics industry. Some medicated skin care manufacturers have already begun combating this competition by marketing their products in a more “cosmetic” fashion.

Swiss retail giant shows interest in aggressively entering OTC market

Herbert Bolliger, president of the Migros supermarket chain, recently announced that the company would like to enter OTC medicine sales. He believes that medicines which do not legally require a consultation with a medical specialist to be sold should be able available in supermarkets such as Migros. Bolliger claims that Migros will sell such OTC drugs at an extreme discount. Presently OTC medicines cost up to 50% less in neighbouring countries such as Germany. Bolliger believes that if OTC medicines are sold on a self-service basis rather than being stored behind counters there would be a major price reduction. So far Migros has the support of the consumer protection agency, which also believes the strategy will bring down the price of OTC medicines. The plan does, however, face major resistance from the association of drugstores (drogisten verband). The association claims that through experiences made in the USA, where OTC medicine can be purchased on a self-service basis, customers too often purchase inappropriate medication or use it improperly due to the lack of consultation.

OTC market expected to continue healthy growth

It is anticipated that the Swiss OTC market will continue to grow at a healthy rate in coming years. Over the forecast period the market is expected to grow from CHF1.2 billion in 2010 to approaching CHF1.4 billion in 2015. Some of the reasons contributing to this growth are the increasing willingness of consumers to self medicate, and the tendency to use natural herbal products. Herbal/traditional products are very much in trend. These products generally do not require a prescription, and therefore such sales will increase the overall OTC performance.

Table of Contents

Table of Contents

Consumer Health in Switzerland - Industry Overview

EXECUTIVE SUMMARY

OTC market continues to grow

Alli enters Swiss OTC market

OTC market receives competition from various other industries

Swiss retail giant shows interest in aggressively entering OTC market

OTC market expected to continue healthy growth

KEY TRENDS AND DEVELOPMENTS

Herbal and traditional medicine in trend

As Swiss seek to remain young, OTC drug sales increase

Swiss consumers opt for less expensive alternatives

Increasingly stressful lifestyles boost OTC sales

Drastically changing demographics influences OTC market

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares by Value 2006-2010
  • Table 6 Consumer Health Brand Shares by Value 2007-2010
  • Table 7 Penetration of Private Label by Category 2005-2010
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Vitamins and dietary supplements’ registration and classification

Self-medication/self-care and preventative medicine

Generics

Switches

  • Summary 1 OTC Healthcare Switches 2008-2010

DEFINITIONS

Category Definitions

  • Summary 2 Research Sources

Consumer Health in Switzerland - Company Profiles

Antistress AG in Consumer Health (Switzerland)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Antistress AG: Competitive Position 2010

Biomed AG in Consumer Health (Switzerland)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 7 Biomed AG: Competitive Position 2010

G Streuli & Co AG in Consumer Health (Switzerland)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 10 G Streuli & Co AG: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 11 G Streuli & Co AG: Competitive Position 2010

Sidroga AG in Consumer Health (Switzerland)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 14 Sidroga AG: Competitive Position 2010

ViforPharma Ltd in Consumer Health (Switzerland)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 17 ViforPharma Ltd : Competitive Position 2010

Adult Mouth Care in Switzerland - Category Analysis

TRENDS

  • Sales of adult mouth care experienced 2% growth in 2010 to reach CHF22 million. The healthy performance can be attributed to the Swiss trend towards focussing on personal appearance and hygiene, including oral hygiene.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2005-2010
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 14 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 15 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Switzerland - Category Analysis

HEADLINES

TRENDS

  • As Swiss consumers lead increasingly busy lives they tend to have more ailments associated with stress, such as headaches. In addition, hectic schedules leave them with little time to recuperate. As a result Swiss consumers tend to take medicines which ease their pain quickly, allowing them to continue with their tight schedules.

SWITCHES

COMPETITIVE LANDSCAPE

  • The Swiss analgesics category is dominated by a few key players, including Novartis with a 12% value share, GlaxoSmithKline on 11%, and ViforPharma Ltd and Bayer both on approaching 10%.

PROSPECTS

  • The analgesics category in Switzerland will continue to grow throughout the forecast period. Sales are anticipated see a 3% constant value CAGR. Growth will continue as people lead stressful lives and thus seek quick and easy solutions to pain. Growth will, however, be limited by an increasing desire to find natural remedies.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2005-2010
  • Table 19 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 21 Analgesics Company Shares by Value 2006-2010
  • Table 22 Analgesics Brand Shares by Value 2007-2010
  • Table 23 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Switzerland - Category Analysis

TRENDS

  • As the Swiss lead increasingly stressful lives, the need for calming and sleeping aids has risen. Sales of over-the-counter calming and sleeping remedies experienced healthy growth throughout the review period. Calming and sleeping aids grew 2% in current value terms in 2010 to reach CHF37 million.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2005-2010
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 27 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 28 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Switzerland - Category Analysis

HEADLINES

TRENDS

  • Cough, cold and allergy remedies’ growth of 3% in 2010 was consistent with the review period CAGR. The number of allergy sufferers in Switzerland is growing, which is positively impacting demand for related medicines. In addition there was a relatively high number of cases of influenza, common cold and other illnesses which served to boost sales of such products.

COMPETITIVE LANDSCAPE

  • Novartis is the leading company in the Swiss over-the-counter cough, cold and allergy remedies environment. Sales of various Novartis products held a value share of 17% at the end of the review period. Contributing to the success of Novartis are highly popular brands Neo Citran and Otrivin.

PROSPECTS

  • Cough, cold and allergy remedies are expected to continue to grow in coming years, with a constant value CAGR of 2% over the forecast period. This expected growth can largely be attributed to the belief that the number of allergy sufferers will continue to grow at a rapid rate.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 33 Sales of Decongestants by Category: Value 2005-2010
  • Table 34 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 35 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 36 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Switzerland - Category Analysis

HEADLINES

TRENDS

  • The busy lifestyles of Swiss consumers are taking a toll on health, as eating habits suffer. Swiss consumers have less time to make home-cooked meals, with an increasing number resorting to more frequent consumption of convenience products. Poor eating habits can cause a variety of digestive problems, in turn increasing the need for over-the-counter remedies.

SWITCHES

COMPETITIVE LANDSCAPE

  • The leader in the Swiss digestive remedies environment at the end of the review period remained Janssen-Cilag AG with a 17% value share. The company’s success is largely due to the popularity of its diarrhoeal remedy Imodium, which generated sales of CHF20 million in 2010 alone. The company has also had success with two other digestive remedy brands, Reasec and Stugeron.

PROSPECTS

  • It is anticipated that sales of digestive remedies will grow throughout the review period reaching a 3% constant value CAGR.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 43 Digestive Remedies Company Shares by Value 2006-2010
  • Table 44 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Switzerland - Category Analysis

TRENDS

  • Sales of ear care in products have been on the decline in Switzerland. Sales dropped by 2% to less than CHF7 million in 2010, continuing the overall review period trend. This statistic may come as a surprise considering that ear issues are often associated with the elderly and that the Swiss population is clearly ageing. The trend, however, is due to the fact that the elderly tend to visit a doctor in relation to ear problems and hence receive prescription drugs for their alignment.

CATEGORY DATA

  • Table 47 Sales of Ear Care: Value 2005-2010
  • Table 48 Sales of Ear Care: % Value Growth 2005-2010
  • Table 49 Ear Care Company Shares by Value 2006-2010
  • Table 50 Ear Care Brand Shares by Value 2007-2010
  • Table 51 Forecast Sales of Ear Care: Value 2010-2015
  • Table 52 Forecast Sales of Ear Care: % Value Growth 2010-2015

Emergency Contraception in Switzerland - Category Analysis

TRENDS

  • Sales of the emergency contraceptive “die Pille danach” continued to soar at the end of the review period. Although the growth rate slowed compared with the 23% increase seen in 2009, sales of the morning after pill still grew by an impressive 20% in current value terms in 2010 to CHF5 million.

CATEGORY DATA

  • Table 53 Sales of Emergency Contraception: Value 2005-2010
  • Table 54 Sales of Emergency Contraception: % Value Growth 2005-2010
  • Table 55 Emergency Contraception Company Shares by Value 2006-2010
  • Table 56 Emergency Contraception Brand Shares by Value 2007-2010
  • Table 57 Forecast Sales of Emergency Contraception: Value 2010-2015
  • Table 58 Forecast Sales of Emergency Contraception: % Value Growth 2010-2015

Eye Care in Switzerland - Category Analysis

TRENDS

  • Sales of eye car products increased almost 2% in 2010, to reach CHF24 million.

CATEGORY DATA

  • Table 59 Sales of Eye Care by Category: Value 2005-2010
  • Table 60 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 61 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 62 Eye Care Company Shares by Value 2006-2010
  • Table 63 Eye Care Brand Shares by Value 2007-2010
  • Table 64 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 65 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Switzerland - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional medicines are very much in trend in Switzerland. Herbal and natural products are seen as safe and healthy options. Herbal/traditional products are popular in various categories, ranging from cough medicines to digestive remedies. Herbal/traditional products have made a major comeback in different categories, such as topical analgesics. One product with significant success in this category is “Wallwurz gel”.

COMPETITIVE LANDSCAPE

  • Ricola remained the clear leader in herbal/traditional products with a 10% value share in 2010. The second most important brand in the herbal/traditional category in 2010 was Denosol, with a 5% value share.

PROSPECTS

  • Sales of herbal/traditional medicines are expected to see a CAGR of 2% over the forecast period. The anticipated growth in sales of herbal/traditional products is due to the reputation of such products as being a safer alternative to standard OTC drugs.

CATEGORY DATA

  • Table 66 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 67 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 68 Herbal/Traditional Products Company Shares 2006-2010
  • Table 69 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 70 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 71 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Switzerland - Category Analysis

HEADLINES

TRENDS

  • A wide variety of very different product types are included in the medicated skin care category, ranging from cosmetic medications such acne and hair loss treatment to antifungals and antipruritics. Many of the cosmetic types of medicated skin care are receiving increasing competition from the cosmetics industry. However, despite heavy competition the sales of all categories of medicated skin care products grew in 2010.

COMPETITIVE LANDSCAPE

  • Bayer (Schweiz) AG was the leader with a 15% value share with sales worth CHF28 million in 2010. Janssen-Cilag AG in second place held a value share of 8% on just over CHF15 million. The third-best performing company was Mundipharma AG with a 7% share and CHF13 million in sales.

PROSPECTS

  • Sales of medicated skin products will grow throughout the forecast period. It is predicted that total sales of OTC medicated skin care will see a 1% constant value CAGR to reach CHF193 million in 2015.

CATEGORY DATA

  • Table 72 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 73 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 74 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 75 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 76 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 77 Acne Treatments Brand Shares by Value 2007-2010
  • Table 78 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 79 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 80 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in Switzerland - Category Analysis

HEADLINES

TRENDS

  • Sales of NRT smoking cessation aids reached CHF17 million in 2010, up 6% in current terms on the previous year. A national smoking ban forbidding patrons from smoking in bars, restaurants, clubs, etc, was introduced in 2010. This has encouraged many smokers to drop the habit, and as a result the growth rate of NRT products more than doubled from just under 3% in 2009.

SWITCHES

COMPETITIVE LANDSCAPE

  • Pfizer AG dominates the Swiss NRT smoking cessation aids environment with its Nicorette brand (GBO Johnson & Johnson Inc), with a value share of 78% in 2010. Nicotinell from Novartis accounted for the remainder of sales.

PROSPECTS

  • Sales of NRT smoking cessation aids will continue to grow throughout the forecast period. Overall sales are expected to see a constant value CAGR of 4%, largely due to the effect of the nationwide smoking ban.

CATEGORY INDICATORS

  • Table 81 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 82 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 83 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 84 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 85 NRT Smoking Cessation Aids Company Shares by Value 2006-2010
  • Table 86 NRT Smoking Cessation Aids Brand Shares by Value 2007-2010
  • Table 87 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 88 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in Switzerland - Category Analysis

HEADLINES

TRENDS

  • Endurance sports such as long-distance cycling, cross-country skiing and running have always been important in Switzerland. In recent years these sports have gained popularity, and as a result many athletes are reaching for sports nutrition products for an extra boost.

COMPETITIVE LANDSCAPE

  • The leading product in 2010 was Sportvital Kreatin from Enervit SpA with a 26% value share and sales worth CHF3.3 million.

PROSPECTS

  • Sales of sports nutrition products are expected to grow over the review period with a constant value CAGR of 3% to reach CHF14 million in 2015.

CATEGORY DATA

  • Table 89 Sales of Sports Nutrition: Value 2005-2010
  • Table 90 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 91 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 92 Sports Nutrition Company Shares 2006-2010
  • Table 93 Sports Nutrition Brand Shares 2007-2010
  • Table 94 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 95 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015
  • Summary 18 Protein ready-to-drink

Vitamins and Dietary Supplements in Switzerland - Category Analysis

HEADLINES

TRENDS

  • The ageing Swiss population has created demand for vitamins and dietary supplements. It is common for the elderly to suffer malnutrition, and as a result this age group is one of the largest consumers of such products. Therefore, as the Swiss population ages demand for vitamins and dietary supplements is increasing accordingly. Vitamins and dietary supplements also benefited from the increasingly hectic lifestyles of consumers and from their desire to maintain health.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • The leading company in 2010 remained Bayer (Schweiz) with a 22% value share achieved through sales worth CHF47 million. Much of this success can be attributed to the company’s popular multivitamin brand Supradyn.

PROSPECTS

  • The Swiss vitamins and dietary supplements environment will continue to grow throughout the forecast period. It is expected to see a CAGR of 2%. Growth is expected to continue due to the ageing of the population.

CATEGORY DATA

  • Table 96 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 97 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 98 Dietary Supplements by Positioning 2005-2010
  • Table 99 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 100 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 101 Vitamins Brand Shares by Value 2007-2010
  • Table 102 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 103 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 104 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015
  • Summary 19 Dietary Supplements: Brand Ranking by Positioning 2010

Weight Management in Switzerland - Category Analysis

HEADLINES

TRENDS

  • Throughout the review period meal replacement products were perceived as unhealthy, and sales dropped dramatically, bringing down the overall growth rate of weight loss products. Meal replacement slimming products saw a current value terms CAGR of -9% over the review period.

COMPETITIVE LANDSCAPE

  • In 2010 the leading product was Formula 1 by Herbalife, a meeal replacement slimming product, acconting for a share of 42% in current value terms. Figure Control, another meal replacement slimming product, ranked second brand. However, these products were affected by the crisis of the meal replacement products niche in 2010, which saw sales drop 8% in current value terms.

PROSPECTS

  • The OTC weight management industry is expected to perform negatively in coming years with an anticipated CAGR of -2% throughout the forecast period. This trend is linked to the negativeconsumer’ perception of meal replacement products, the most important sector in weight management.

CATEGORY DATA

  • Table 105 Sales of Weight Management: Value 2005-2010
  • Table 106 Sales of Weight Management: % Value Growth 2005-2010
  • Table 107 Weight Management Company Shares 2006-2010
  • Table 108 Weight Management Brand Shares 2007-2010
  • Table 109 Forecast Sales of Weight Management: Value 2010-2015
  • Table 110 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in Switzerland - Category Analysis

TRENDS

  • Wound care sales grew at a CAGR of 1% in current value terms in 2010. Total sales grew 12% over the review period from CHF27 million in 2005 to CHF30 million in 2010. Sticking plasters remained by far the largest category with nearly CHF18 million in sales. The “gauze, tape and other” niche was the second-largest with sales worth almost CHF10 million. First aid kits represented the smallest segment with annual sales of CHF3 million in 2010.

CATEGORY DATA

  • Table 111 Sales of Wound Care by Category: Value 2005-2010
  • Table 112 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 113 Wound Care Company Shares by Value 2006-2010
  • Table 114 Wound Care Brand Shares by Value 2007-2010
  • Table 115 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 116 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Artichoke
            • Isoflavones
            • Pumpkin Seed
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Silica
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Child-Specific Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Child-Specific Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Child-Specific Consumer Health
      • Child-Specific Analgesics
        • Child-Specific Acetaminophen
        • Child-Specific Aspirin
        • Child-Specific Combination Products - Analgesics
        • Child-Specific Diclofenac
        • Child-Specific Dipyrone
        • Child-Specific Ibuprofen
        • Child-Specific Ketoprofen
        • Child-Specific Naproxen
      • Child-Specific Cough, Cold and Allergy Remedies
        • Child-Specific Allergy Remedies
        • Child-Specific Cough/Cold Remedies
      • Child-Specific Digestive Remedies
        • Child-Specific Diarrhoeal Remedies
        • Child-Specific Indigestion and Heartburn Remedies
        • Child-Specific Laxatives
        • Child-Specific Motion Sickness Remedies
      • Child-Specific Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Child-Specific Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking incidence

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

RELATED

Country Report

Consumer Lifestyle

Future Demographic

Country Report